Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 12 studies | 69% ± 24% | |
| GABAergic neuron | 10 studies | 58% ± 25% | |
| interneuron | 6 studies | 58% ± 31% | |
| cardiac muscle cell | 6 studies | 57% ± 19% | |
| neuron | 5 studies | 31% ± 15% | |
| epithelial cell | 4 studies | 43% ± 16% | |
| granule cell | 4 studies | 42% ± 8% | |
| amacrine cell | 4 studies | 48% ± 24% | |
| retinal ganglion cell | 4 studies | 80% ± 11% | |
| endothelial cell | 3 studies | 47% ± 21% | |
| GABAergic interneuron | 3 studies | 66% ± 4% | |
| retinal bipolar neuron | 3 studies | 65% ± 35% | |
| OFF-bipolar cell | 3 studies | 65% ± 16% | |
| ON-bipolar cell | 3 studies | 75% ± 13% | |
| glycinergic amacrine cell | 3 studies | 40% ± 8% | |
| rod bipolar cell | 3 studies | 76% ± 30% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 98% | 738.00 | 320 / 328 | 38% | 1.38 | 68 / 178 |
| brain | 85% | 1046.80 | 2236 / 2642 | 27% | 0.93 | 192 / 705 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.70 | 1 / 1 |
| heart | 98% | 4720.22 | 842 / 861 | 0% | 0 | 0 / 0 |
| ovary | 78% | 474.42 | 141 / 180 | 7% | 0.11 | 29 / 430 |
| bladder | 33% | 152.95 | 7 / 21 | 25% | 1.88 | 124 / 504 |
| blood vessel | 58% | 1649.58 | 769 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 53% | 486.85 | 764 / 1445 | 4% | 0.14 | 8 / 183 |
| uterus | 36% | 175.61 | 62 / 170 | 17% | 1.11 | 78 / 459 |
| prostate | 2% | 6.77 | 5 / 245 | 39% | 0.87 | 196 / 502 |
| liver | 32% | 117.87 | 72 / 226 | 3% | 0.09 | 14 / 406 |
| stomach | 30% | 243.84 | 107 / 359 | 5% | 0.21 | 14 / 286 |
| intestine | 30% | 119.38 | 289 / 966 | 4% | 0.14 | 20 / 527 |
| thymus | 13% | 54.49 | 87 / 653 | 17% | 0.53 | 103 / 605 |
| adrenal gland | 1% | 5.33 | 2 / 258 | 30% | 1.26 | 68 / 230 |
| spleen | 13% | 44.34 | 32 / 241 | 0% | 0 | 0 / 0 |
| lung | 3% | 16.31 | 19 / 578 | 6% | 0.22 | 73 / 1155 |
| breast | 1% | 2.53 | 3 / 459 | 8% | 0.20 | 94 / 1118 |
| kidney | 0% | 0 | 0 / 89 | 8% | 0.24 | 68 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.16 | 3 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.29 | 1 / 29 |
| skin | 2% | 4.75 | 29 / 1809 | 1% | 0.03 | 5 / 472 |
| adipose | 3% | 8.35 | 31 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.09 | 2 / 80 |
| muscle | 1% | 2.27 | 5 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.33 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005813 | Cellular component | centrosome |
| GO_0015630 | Cellular component | microtubule cytoskeleton |
| GO_0005881 | Cellular component | cytoplasmic microtubule |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0045171 | Cellular component | intercellular bridge |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0008017 | Molecular function | microtubule binding |
| Gene name | MTUS2 |
| Protein name | Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150) (Tracking protein of 150 kDa) |
| Synonyms | TIP150 KIAA0774 CAZIP |
| Description | FUNCTION: Binds microtubules. Together with MAPRE1 may target the microtubule depolymerase KIF2C to the plus-end of microtubules. May regulate the dynamics of microtubules at their growing distal tip. . |
| Accessions | Q5JR59 ENST00000380808.6 [Q5JR59-3] ENST00000612955.6 [Q5JR59-2] ENST00000542829.1 [Q5JR59-4] |